Perrigo | PRGO - Operating Profit


Perrigo reported $27.2M in Operating Profit for its fiscal quarter ending in September of 2026.





Operating Profit Change Date
AbbVie USD 6.88B 156M Sep/2026
Abbott USD 1.36B 775M Sep/2026
Bayer EUR 129M 698M Sep/2026
Bristol-Myers Squibb USD 255M 44M Sep/2026
Coherus Biosciences USD -39.08M 3.65M Dec/2025
Corcept Therapeutics USD 114.72M 73.42M Sep/2026
Dr.Reddys Laboratories INR 12.16B 8.91B Sep/2026
Eli Lilly USD 12.46B 2.68B Jun/2026
J&J USD 6.47B 1B Sep/2026
Merck USD 7.33B 6.49B Sep/2026
Nestle CHF 6.98B 133M Jun/2026
Pacira USD 2.57B 2.56B Sep/2026
Perrigo USD 27.2M 3.7M Sep/2026
Pfizer USD 662M 5M Sep/2026
Phibro Animal Health USD 54.99M 2.36M Dec/2025
Prestige Brands USD 52.52M 22.97M Jun/2026
Reckitt Benckiser GBP 747M 92M Dec/2024
Sanofi EUR 4.72B 2.34B Sep/2026
Supernus Pharmaceuticals USD -21.04M 14.21M Jun/2026
Teva Pharmaceutical Industries USD 1.19B 954M Sep/2026
Xeris Pharmaceuticals USD 5.17M 2.74M Jun/2026
Zoetis USD 1.03B 88M Sep/2026